Related Experiment Video
Updated: Jul 29, 2025

A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse
Published on: December 16, 2022
Morphological and genetic causes of fetal cardiomyopathies
Eva Kohaut1, Flavie Ader2, Caroline Rooryck3
1APHP-Service de Génétique Clinique, Hôpital Necker, Paris, France.
Insights
Genetic testing aids in diagnosing severe early-onset cardiomyopathies in infants. This approach identifies genetic causes, enabling crucial genetic counseling and early detection in at-risk parents.
Area of Science:
- Genetics
- Cardiology
- Pediatrics
Background:
- Cardiomyopathies are heart muscle diseases with diverse presentations.
- Severe forms can manifest antenatally, leading to poor outcomes.
- Genetic heterogeneity and variable phenotypes complicate diagnosis.
Purpose of the Study:
- To investigate the genetic basis of severe early-onset cardiomyopathies in fetuses, newborns, and infants.
- To evaluate the diagnostic utility of genetic testing in these cases.
- To facilitate genetic counseling and identify at-risk family members.
Main Methods:
- Morphological and histological examination of cardiac tissue.
- Targeted next-generation sequencing (NGS) panel analysis for cardiac genes.
- Systematic parental testing to identify carriers and assess recurrence risk.
Main Results:
- Identified the genetic cause in 8 out of 11 families.
- Detected various mutation types, including compound heterozygous, co-dominant, and de novo mutations.
- Confirmed germline mosaicism in one family and identified presymptomatic carriers through parental testing.
Conclusions:
- Genetic testing is highly valuable for diagnosing severe antenatal cardiomyopathies.
- This diagnostic approach is essential for providing accurate genetic counseling.
- Early genetic identification allows for proactive cardiological surveillance of at-risk individuals.
Abstract:
Cardiomyopathies are diseases of the heart muscle with variable clinical expressivity. Most of forms are inherited as dominant trait, and with incomplete penetrance until adulthood. Severe forms of cardiomyopathies were observed during the antenatal period with a pejorative issue leading to fetal death or medical interruption of pregnancy. Variable phenotypes and genetic heterogeneity make etiologic diagnosis difficult. We report 11 families (16 cases) whose unborn, newborn or infant with early onset cardiomyopathies. Detailed morphological and histological examinations of hearts were implemented, as well as genetic analysis on a cardiac targeted NGS panel. This strategy allowed the identification of the genetic cause of the cardiomyopathy in 8/11 families. Compound heterozygous mutations in dominant adulthood cardiomyopathy genes were found in two, pathogenic variants in co-dominant genes in one, de novo mutations in 5 including a germline mosaicism in one family. Parental testing was systematically performed to detect mutation carriers, and to manage cardiological surveillance and propose a genetic counseling. This study highlights the great diagnostic value of the genetic testing of severe antenatal cardiomyopathy both for genetic counseling and to detect presymptomatic parents at higher risk of developing cardiomyopathy.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis I: Introduction
Heart Failure II: Pathophysiology

